Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Feb 17 2000
EXECUTIVE SUMMARY BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states...
Feb 14 2000
WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and...
Feb 10 2000
WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a...
Feb 8 2000
WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Jan 27 2000
WASHINGTON, D.C. (Jan. 27, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement on Medicare...
Jan 21 2000
WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding...
Jan 20 2000
CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the...
Jan 18 2000
WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington...
Jan 18 2000
WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug...


Biotechnology News

October 30, 2014

DOYLESTOWN, Pa.--(BUSINESS WIRE)--Marcum LLP and Philadelphia SmartCEO recognized the area’s top leaders in innovation at the 2014 Marcum Innovator of the Year Awards,...

October 30, 2014

BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) announces that three Johnson & Johnson Diabetes Solutions Companies have joined JITT as...

October 30, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented the results of a Phase 2/3 study of its investigational 20 percent concentration subcutaneous immunoglobulin treatment...

October 30, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Phase 2 Objective Response Rate&Survival Data for Opdivo(nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung...

October 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and...